Ambuja Cements (AMBUJACEM) — deviation variation

📢 Key Event
No deviation in fund utilization for preferential issue

💡 Investor Takeaway
Funds were fully deployed as originally planned with no scope changes.

Ambuja Cements confirmed no deviation in fund utilization for its Rs 15,000.046 crores preferential issue during Q1 FY2026, with full deployment matching original capital expenditure plans for plant optimization and ESG initiatives, as verified by its Audit Committee on July 28, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How was the Rs 15,000.046 crores fund deployment distributed across capital expenditures and working capital?" "What specific ESG compliance targets were achieved through the digitization investment?" "How does this fund utilization compare to peers' preferential issue deployments in the cement sector?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 28 July 2026

LT Larsen & Toubro Limited Corporate Action TI Tilaknagar Industries Limited Financial Results LGBBROSLTD LG Balakrishnan & Bros Limited Announcement MAXIND Max India Limited Annual Report RVNL Rail Vikas Nigam Limited Corporate Action NIRAJ Niraj Cement Structurals Limited Offer Document

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.